CytoImmune Therapeutics and Biosimilar Sciences US to Move Biotechnology Operations to Puerto Rico
By EsqSocial Corporation 08/02/21
With the support of the economic development organization Invest Puerto Rico, Biosimilar Solutions LLC announced that both it and CytoImmune Therapeutics will be establishing operations on the island to conduct biologics and cell therapy research and development. According to the press release, CytoImmune will relocate to Toa Baja and plans to invest $28 million in the facility, which will be developing and marketing novel cancer immunotherapy products....
By: Goodwin